Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation

Tekijä Hernæs, Kjersti Helene, Smeland, Knut B., Fagerli, Unn-Merete, Kiserud, Cecilie E.
Julkaisussa BMC Cancer (2021)

c-Met signaling promotes IL-6-induced myeloma cell proliferation

Tekijä Hov, Håkon, Tian, Erming, Holien, Toril, Holt, Randi Utne, Våtsveen, Thea K, Fagerli, Unn-Merete, Waage, Anders, Børset, Magne, Sundan, Anders
Julkaistu 2009

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

Tekijä Hjort, Magnus Aassved, Hov, Håkon, Abdollahi, Pegah, Vandsemb, Esten Nymoen, Fagerli, Unn-Merete, Lund, Bendik, Slørdahl, Tobias Schmidt, Børset, Magne, Rø, Torstein Baade
Julkaisussa Exp Hematol Oncol (2018)

Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas

Tekijä Fevang, Børre, Fagerli, Unn Merete, Sorte, Hanne, Aarset, Harald, Hov, Håkon, Langmyr, Marit, Keil, Thomas Morten, Bjørge, Ellen, Aukrust, Pål, Stray-Pedersen, Asbjørg, Gedde-Dahl, Tobias
Julkaisussa Case Reports Immunol (2018)

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis

Tekijä Brenne, Anne-Tove, Fagerli, Unn-Merete, Shaughnessy, John D, Våtsveen, Thea Kristin, Rø, Torstein Baade, Hella, Hanne, Zhan, Fenghuang, Barlogie, Bart, Sundan, Anders, Børset, Magne, Waage, Anders
Julkaistu 2009

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: result...

Tekijä Pulczynski, Elisa J., Kuittinen, Outi, Erlanson, Martin, Hagberg, Hans, Fosså, Alexander, Eriksson, Mikael, Nordstrøm, Marie, Østenstad, Bjørn, Fluge, Øystein, Leppä, Sirpa, Fiirgaard, Bente, Bersvendsen, Hanne, Fagerli, Unn-Merete
Julkaisussa Haematologica (2015)

Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

Tekijä Smeland, Knut B., Kiserud, Cecilie E., Lauritzsen, Grete F., Fagerli, Unn-Merete, Falk, Ragnhild S., Fluge, Øystein, Fosså, Alexander, Kolstad, Arne, Loge, Jon H., Maisenhölder, Martin, Kvaløy, Stein, Holte, Harald
Julkaisussa Haematologica (2015)

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

Tekijä Fagerli, Unn-Merete, Holt, Randi U., Holien, Toril, Vaatsveen, Thea K., Zhan, Fenghuang, Egeberg, Kjartan W., Barlogie, Bart, Waage, Anders, Aarset, Harald, Dai, Hong Yan, Shaughnessy, John D., Sundan, Anders, Børset, Magne
Julkaistu 2008

Phase 1/2a study of (177)Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Tekijä Kolstad, Arne, Illidge, Tim, Bolstad, Nils, Spetalen, Signe, Madsbu, Ulf, Stokke, Caroline, Blakkisrud, Johan, Løndalen, Ayca, O'Rourke, Noelle, Beasley, Matthew, Jurczak, Wojciech, Fagerli, Unn-Merete, Kaščák, Michal, Bayne, Mike, Obr, Aleš, Dahle, Jostein, Rojkjaer, Lisa, Pascal, Veronique, Holte, Harald
Julkaisussa Blood Adv (2020)

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

Tekijä Eskelund, Christian Winther, Dimopoulos, Kostas, Kolstad, Arne, Glimelius, Ingrid, Räty, Riikka, Gjerdrum, Lise Mette Rahbek, Sonnevi, Kristina, Josefsson, Pär, Nilsson-Ehle, Herman, Bentzen, Hans H. N., Fagerli, Unn Merete, Kuittinen, Outi, Haaber, Jacob, Niemann, Carsten Utoft, Pedersen, Lone Bredo, Larsen, Maria Torp, Geisler, Christian Hartmann, Hutchings, Martin, Jerkeman, Mats, Grønbæk, Kirsten
Julkaisussa Hemasphere (2020)

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Tekijä Leppä, Sirpa, Jørgensen, Judit, Tierens, Anne, Meriranta, Leo, Østlie, Ingunn, de Nully Brown, Peter, Fagerli, Unn-Merete, Larsen, Thomas Stauffer, Mannisto, Susanna, Munksgaard, Lars, Maisenhölder, Martin, Vasala, Kaija, Meyer, Peter, Jerkeman, Mats, Björkholm, Magnus, Fluge, Øystein, Jyrkkiö, Sirkku, Liestøl, Knut, Ralfkiaer, Elisabeth, Spetalen, Signe, Beiske, Klaus, Karjalainen-Lindsberg, Marja-Liisa, Holte, Harald
Julkaisussa Blood Adv (2020)

Nordic MCL3 study: (90)Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Tekijä Kolstad, Arne, Laurell, Anna, Jerkeman, Mats, Grønbæk, Kirsten, Elonen, Erkki, Räty, Riikka, Pedersen, Lone Bredo, Loft, Annika, Bogsrud, Trond Velde, Kimby, Eva, Hansen, Per Boye, Fagerli, Unn-Merete, Nilsson-Ehle, Herman, Lauritzsen, Grete Fossum, Lehmann, Anne Kristine, Sundstrom, Christer, Karjalainen-Lindsberg, Marja-Liisa, Ralfkiaer, Elisabeth, Ehinger, Mats, Delabie, Jan, Bentzen, Hans, Schildt, Jukka, Kostova-Aherdan, Kamelia, Frederiksen, Henrik, Brown, Peter de Nully, Geisler, Christian H.
Julkaistu 2014